Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration

Human Reproduction

Volumn 14, Issue 10, 1999, Pages 2437-2441

  Ludwig, M ^a   Jelkmann, W ^a   Bauer, O ^a   Diedrich, K ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

OHSS; Ovarian stimulation; Pregnancy; VEGF

Indexed keywords

CHORIONIC GONADOTROPIN; GOSERELIN; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO; EMBRYO TRANSFER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; OVARY DISEASE; PROSPECTIVE STUDY;

FALLOPIA;

EID: 0032828555     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.10.2437     Document Type: Article

References (39)

1. Aboulghar, M.A., Mansour, R.T., Serour, G.I. et al. (1998) Elevated concentrations of angiogenin in serum and ascitic fluid from patients with severe ovarian hyperstimulation syndrome. Hum. Reprod., 13, 2068-2071.
2. Abramov, Y., Barak, V., Nisman, B. and Schenker, J.G. (1997) Vascular endothelial growth factor plasma concentrations correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil. Steril., 67, 261-265.
3. Ambramov, Y, Naparstek.Y, Elchalal, U. et al. (1999) Plasma immunoglobulins in patients with severe ovarian hyperStimulation syndrome. Fertil. Steril., 70, 102-105.
4. Agarwal, R., Conway, G., Sladkevicius, P. et al. (1998) Serum vascular endothelial growth factor and Doppler blood flow velocities in in vitro fertilization: relevance to ovarian hyperstimulation syndrome and polycystic ovaries. Fertil. Steril., 70, 651-658.
5. Agarwal, R., Conway, O.S., Payne, N. and Jacobs, H.S. (1997) Vascular endothelial growth factor secretion in women undergoing ovarian stimulation: relevance to ovarian hyperstimulation syndrome. Joint meeting of the British Endocrine Societies, Harrogate, UK, 07.10.04, abstract 16.
6. Agarwal, R., Tan, S-L., Wild, S. et al. (1999) Serum vascular endothelial growth factor concentrations in m vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome. Fertil. Steril., 71, 287-293.
7. Anthony, F.W., Evans, P.W., Wheeler, T. and Wood, P.J. (1997) Variation in detection of VEGF in maternal serum by immunoassay and the possible influence of binding proteins. Ann. Clin. Biochem., 34, 276-280.
8. Artini, P.O., Fasciani, A., Monti, M. et al. (1998) Changes in vascular endothelial growth factor concentrations and the risk of ovarian hyperstimulation syndrome in women enrolled in an m vitro fertilization program. Fenil. Steril., 70, 560-564.
9. Ben Rafael, Z., Orvieto, R., Dekel, A. et al. (1995) Intravenous albumin and the prevention of severe ovarian hyperstimulation syndrome [letter; comment]. Hum. Reprod., 10, 2750-2752.
10. Benadiva, C.A., Davis, O., Kligman, I. et al. (1997) Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil. Steril., 67, 724-727.
11. Bienvenu, J., Coulon, L., Doche, C. et al. (1993) Analytical performances of commercial ELISA-kits for IL-2, IL6 and TNF-ct. A WHO study. Eur. Cytokine Net\v., 4, 447-451.
12. Delbaere, A., Bergmann, P.J., Gervy-Decoster, C. et al. (1997) Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Hum. Reprod., 12, 236-240.
13. Doldi, N., Destefani, A., Gessi, A. et al. (1999) Human albumin enhances expression of vascular endothelial growth factor in cultured human luteinizing granulosa cells: importance in ovarian hyperstimulation syndrome. Hum. Reprod., 14, 1157-1159.
14. Elchalal, U. and Schenker, J.G. (1997) The pathophysiology of ovarian hyperstimulation syndrome -views and ideas. Hum. Reprod., 12, 1129-1137.
15. Evans, P.W., Wheeler, T., Anthony, F. and Osmond, C. (1997) Maternal serum vascular endothelial growth factor during early pregnancy, Clin. Sci., 92, 567-571.
16. Ferrara, N., Chen, H., Davis-Symth, T. et al. (1998) Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nature Med., 4, 336-340.
17. Heils, F., Katschinski, D.M., Wiedemann, G.J. et al. (1997) Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients. Int. J. Oncol., 10, 333-337.
18. Itskovitz-Eldor, J., Kol, S., Lewit, N. and Sealey, J.E. (1997) Ovarian origin of plasma and peritoneal fluid prorenin in early pregnancy and in patients with ovarian hyperstimulation syndrome. J. Clin. Endocrinol Metab., 82, 461-464.
19. Kobayashi, H., Okada, Y, Asahina, T. et al. (1998) The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome. J. Mol. Endocrinol., 20, 363-374.
20. Kodama, H., Takeda, S., Fukuda, J. et al. (1997) Activation of plasma kinin system correlates with severe coagulation disorders in patients with ovarian hyperstimulation syndrome. Hum. Reprod., 12, 891-895.
21. Krasnow, J.S., Berga, S.L., Guzick, D.S. et al. (1996) Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril., 65, 552-555.
22. Lee, A., Christenson, L.K., Patton, P.E. et al. (1997a) Vascular endothelial growth factor production by human luteinized granulosa cells m vitro. Hum. Reprod., 12, 2756-2761.
23. Lee, A., Christenson, L.K., Stouffer, R.L. et al. (1997b) Vascular endothelial growth factor concentrations in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil. Steril., 68, 305-311.
24. Lee, C., Tummon, I., Martin, J. etal. (1998) Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome? Hum. Reprod., 13, 1157-1158.
25. Licht, R, Engel, N., Fischer, O. et al. (1997) HCG does not directly regulate circulating concentrations of vascular endothelial growth factor in IVF and embryo transfer cycles. Huin. Reprod. (abstract book), 12, 6.
26. Ludwig, M., Bauer, O., Lopens, A. et al. (1998a) Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome. Hum. Reprod., 13, 30-32.
27. Ludwig, M., Gembruch, U., Bauer, O. and Diedrich, K. (1998b) Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: information about the general pathophysiology of OHSS. Hum. Reprod., 13, 2082-2087.
28. Lyall, F., Greer, I.A., Boswell, F. and Fleming, R. (1997) Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br. J. Obstet. Gynaecol., 104, 223-228.
29. Neulen J., Yan Z., Raczek S. el al. (1995) Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Melab., 80, 1967-1971.
30. Ng, E., Leader, A., Claman, P. et al. (1995) Intravenous albumin does not prevent the development of severe ovarian hyperstimulation syndrome in an in-vitro fertilization programme. Hum. Reprod., 10, 807-810.
31. Orvieto, R. and Ben-Rafael, Z. (1998) Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome. Hum. Reprod., 13, 3306-3309.
32. Orvieto, R. and Ben Rafael, Z. (1996) Prophylactic intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome [letter]. Hum. Reprod., 11, 460-461.
33. Radoux.D. and DeGroote.D. (1994) The total cytokine concept: the influence of soluble receptors in the cytokine measurement Contrib. Onco., 46, 251-259.
34. Rizk, B., Aboulghar, M., Smitz, J. and Ron-El, R. (1997) The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome. Hum. Reprod. Update, 3, 255-266.
35. Sabatini, L, Wilson, C., al Shawaf, T. et al. (1997) Efficacy of serum albumin to prevent ovarian hyperstimulation syndrome? [letter; comment]. Fenil. Steril., 67, 587-589.
36. Shaker, A.G., Zosmer, A., Dean, N. et al. (1996) Comparison of intravenous albumin and transfer of fresh embryos with cryopreservation of all embryos for subsequent transfer in prevention of ovarian hyperstimulation syndrome. Fertil. Steril., 65, 992-996.
37. Shalev, E., Giladi, Y., Matilsky, M. and Ben Ami, M. (1995) Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin, a prospective study. Hum. Reprod., 10, 1373-1376.
38. Sharkey, A.M., Cooper, J.C., Balmforth, J.R. et al. (1996) Maternal plasma concentrations of vascular endothelial growth factor in normotensive pregnancies and in pregnancies complicated by pre-eclampsia. Europ. J. Clin. Invest., 26, 1182-1185.
39. WHO (1973) Agents stimulatins gonadal function in human. World Health organ. Tech. Rep. Ser, 514-520.